Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus formulation switch study in stable kidney transplant recipients
NL-OMON46874Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in kidney transplant (3 arms), sponsored by Erasmus MC. Started Sep 2016; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON46874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46874.